Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
D
DongKook Life Science Co Ltd
KOSDAQ:303810
DongKook Life Science Co Ltd
KOSDAQ:303810
Price:
2 750
KRW
-1.96%
Market Closed
Market Cap:
₩87.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
D
|
DongKook Life Science Co Ltd
KOSDAQ:303810
|
KR |
|
S
|
Semperit Holding AG
LSE:0G29
|
AT |
|
B
|
Bpost SA
XMUN:13B
|
BE |
|
K
|
KH Construction Co Ltd
KOSDAQ:226360
|
KR |
|
V
|
Valiant Gold Ltd
XMUN:LFY
|
AU |
|
D
|
Dolmen City REIT
KAR:DCR
|
PK |
|
Satyamitra Kemas Lestari Tbk PT
IDX:SMKL
|
ID |
|
W
|
Webac Holding AG
F:RKB
|
DE |
|
T
|
Taigen Biopharmaceuticals Holdings Ltd
TPEX:4157
|
TW |
|
Cordoba Minerals Corp
F:7C6A
|
CA |
|
Sequana Medical NV
XBRU:SEQUA
|
BE |
|
E
|
Egide SA
F:EGID
|
FR |
|
DTS Corp
F:DA9
|
JP |
|
Reach Resources Ltd
OTC:RRLTF
|
AU |
|
U
|
UK Arsagera PAO
MOEX:ARSA
|
RU |
|
T
|
Tessenderlo Group NV
SWB:TEZ
|
BE |
|
IP Group PLC
LSE:IPO
|
UK |
|
S
|
Sheng Yi Development Co Ltd
TPEX:5455
|
TW |
|
W
|
Wonik Holdings Co Ltd
KOSDAQ:030530
|
KR |
|
C
|
CenterPoint Energy Inc
DUS:HOU
|
US |
|
Indonesia Pondasi Raya Tbk PT
IDX:IDPR
|
ID |
|
A
|
Aikchol Hospital PCL
SET:AHC
|
TH |
|
TNS Energo Yaroslavl PAO
MOEX:YRSBP
|
RU |
|
Topaz Resources Inc
OTC:TOPZ
|
US |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DongKook Life Science Co Ltd's stock price target?
Not Available
DongKook Life Science Co Ltd does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for DongKook Life Science Co Ltd?
Projected CAGR
22%
22%
Over the last 2 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 2 years is 22%.
What is the Operating Income forecast for DongKook Life Science Co Ltd?
Projected CAGR
23%
23%
Over the last 2 years, the compound annual growth rate for Operating Income has been 24%. The projected CAGR for the next 2 years is 23%.